1. Ester modification at the 3′ end of anti-microRNA oligonucleotides increases potency of microRNA inhibition
- Author
-
Pham, Kevin M, Suter, Scott R, Lu, Shannon S, and Beal, Peter A
- Subjects
Medicinal and Biomolecular Chemistry ,Chemical Sciences ,Prevention ,Biotechnology ,Vaccine Related ,Genetics ,Development of treatments and therapeutic interventions ,5.1 Pharmaceuticals ,Argonaute Proteins ,Cell Line ,Click Chemistry ,Drug Evaluation ,Preclinical ,Esters ,Exonucleases ,Humans ,MicroRNAs ,Molecular Docking Simulation ,Oligonucleotides ,Oligonucleotides ,Antisense ,Phosphoric Diester Hydrolases ,Protein Conformation ,Small Molecule Libraries ,Structure-Activity Relationship ,Triazoles ,RNA interference ,MicroRNA ,Anti-microRNA ,Click chemistry ,Molecular docking ,Argonaute2 ,Organic Chemistry ,Pharmacology and Pharmaceutical Sciences ,Medicinal & Biomolecular Chemistry ,Biochemistry and cell biology ,Medicinal and biomolecular chemistry ,Organic chemistry - Abstract
MicroRNAs (miRNAs) are short noncoding RNAs that play a fundamental role in gene regulation. Deregulation of miRNA expression has a strong correlation with disease and antisense oligonucleotides that bind and inhibit miRNAs associated with disease have therapeutic potential. Current research on the chemical modification of anti-miRNA oligonucleotides (anti-miRs) is focused on alterations of the phosphodiester-ribose backbone to improve nuclease resistance and binding affinity to miRNA strands. Here we describe a structure-guided approach for modification of the 3'-end of anti-miRs by screening for modifications compatible with a nucleotide-binding pocket present on human Argonaute2 (hAgo2). We computationally screened a library of 190 triazole-modified nucleoside analogs for complementarity to the t1A-binding pocket of hAgo2. Seventeen top scoring triazoles were then incorporated into the 3' end of anti-miR21 and potency was evaluated for each in a cell-based assay for anti-miR activity. Four triazole-modified anti-miRs showed higher potency than anti-miR21 bearing a 3' adenosine. In particular, a triazole-modified nucleoside bearing an ester substituent imparted a nine-fold and five-fold increase in activity for both anti-miR21 and anti-miR122 at 300 and 5 nM, respectively. The ester group was shown to be critical as a similar carboxylic acid and amide were inactive. Furthermore, anti-miR 3' end modification with triazole-modified nucleoside analogs improved resistance to snake venom phosphodiesterase, a 3'-exonuclease. Thus, the modifications described here are good candidates for improvement of anti-miR activity.
- Published
- 2021